Hypothesizing that gene amplification leads to an increase in protein expression, IL10 immunosuppressive properties could the metastatic potential of breast cancer, increasing the risk of lymph node involvement, which represents a well-known predisposing factor for BCLR. Here, IL10 is linked to breast cancer.